Trials & Tribulations Re: Drug Pricing My unsolicited advice to HHS Secretary Alex Azar February 02, 2018Vol.44 No.05By Patricia J. Goldsmith
FreeTrials & Tribulations Hybrid cancer centers exploring links with NCI-designated institutions January 26, 2018Vol.44 No.04By Derek Raghavan, Nicholas J. Petrelli and Donald L. "Skip" Trump
FreeTrials & Tribulations How disease-specific clinical trial finders can address gaps in study participation January 12, 2018Vol.44 No.02By David F. Arons
FreeTrials & Tribulations Cabozantinib in first-line treatment of metastatic renal cell carcinoma January 05, 2018Vol.44 No.01By Tian Zhang, Michael J. Morris, Darren R. Feldman, Toni K. Choueiri and Daniel J. George
Liquid biopsy results differed substantially between two providers in a study December 29, 2017Vol.40 No.11
Aggressive surgery is best treatment option for early stage lung cancer December 29, 2017Vol.40 No.11
Galera Therapeutics reports statistically significant results in a 223-patient phase IIb trial of GC4419 for oral mucositis in head and neck cancer December 29, 2017Vol.40 No.11
PD-1 antibody cemiplimab demonstrates 46.3% ORR in advanced cutaneous squamous cell carcinoma December 29, 2017Vol.40 No.11
